Merck soars on Keytruda combination filing
January 12, 2017Approval by May could put Keytruda in pole position
X
Merck soars on Keytruda combination filing
https://pharmaphorum.com/news/merck-soars-keytruda-combination-filing/
Keytruda
Merck and Lilly expand alliance with Keytruda + Lartruvo trial
January 11, 2017
Cancer market commentary: Roche’s Tecentriq muscles into NSCLC
October 10, 2016Roche’s PD-L1 drug has generated impressive data in second line lung cancer
Cancer Market Commentary: Keytruda’s triumph not the last word in NSCLC
October 10, 2016Despite Keytruda’s overwhelming victory, it’s not over yet in NSCLC
Eye on ESMO: Day 1 – Access in spotlight before data deluge
October 8, 2016Europe’s biggest cancer conference ESMO is underway
Merck makes its move: Keytruda filed for first line lung cancer
September 7, 2016Merck steals a march on rival BMS.
Promise for combination approach to cancer
August 15, 2016As immuno-oncology increasingly involves more than one agent for best efficacy, market positioning must take a pan-tumour approach.
